Biotech

All Articles

Capricor allotments more records for DMD therapy after triggering BLA

.Capricor Therapies is actually taking a triumph tour for their stage 2 Duchenne muscle dystrophy (D...

FDA locations Kezar lupus trial in hold following 4 client deaths

.The FDA has positioned Kezar Life Sciences' lupus test on grip after the biotech flagged four fatal...

Phase 3 Academic Stone trial strikes SMA target, delivering stockpile 200%

.A stage 3 trial of Academic Rock's vertebral muscle atrophy (SMA) prospect has actually hit its own...

CAMP 4 is actually latest to eye IPO, while Upstream spells out $182M plan

.RNA biotech CAMP4 Therapeutics has defined think about a $67 million IPO, with inflammation-focused...

Galecto buys leukemia medicine, falls bone cancer property in pivot

.A year after the failure of an idiopathic pulmonary fibrosis candidate sent out Galecto on a hunt f...

Judo tosses down $100M to knock out kidney ailment

.Taking the floor covering is Judo Biography, an up-and-coming biotech equipped along with $one hund...

AstraZeneca pays out CSPC $100M for preclinical heart disease drug

.AstraZeneca has paid CSPC Drug Group $one hundred thousand for a preclinical cardiovascular disease...

Zephyrm finds Hong Kong IPO to finance stage 3 tissue treatment trials

.Zephyrm Bioscience is gusting toward the Hong Kong stock market, submitting (PDF) for an IPO to ban...

Frazier Life Sciences collects $630M for tiny, mid-cap biotechs

.Frazier Lifespan Sciences has actually sourced an even further $630 thousand for its fund focused o...

GigaGen achieves approximately $135M BARDA dollars to hammer botox

.Antibody fanatic GigaGen, a subsidiary of Spanish biopharma Grifols, is actually increase its own t...